PND3 Improvements in Migraine-specific Quality of Life Questionnaire (MSQ) Domain Scores with Fremanezumab and Galcanezumab in Patients with Multiple Prior Migraine Preventive Treatment Failures: A Network Meta-analysis
Abstract
Authors
F. Mu M.T. Driessen J.M. Cohen Y. Wang R. Ayyagari